245 related articles for article (PubMed ID: 9049879)
21. Enhanced IUdR radiosensitization by 241Am photons relative to 226Ra and 125I photons at 0.72 Gy/hr.
Nath R; Bongiorni P; Rossi PI; Rockwell S
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1377-85. PubMed ID: 2370187
[TBL] [Abstract][Full Text] [Related]
22. Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain.
Brem H; Kader A; Epstein JI; Tamargo RJ; Domb A; Langer R; Leong KW
Sel Cancer Ther; 1989; 5(2):55-65. PubMed ID: 2772427
[TBL] [Abstract][Full Text] [Related]
23. Enhancement radiation-induced apoptosis in C6 glioma tumor-bearing rats via pH-responsive magnetic graphene oxide nanocarrier.
Shirvalilou S; Khoei S; Khoee S; Mahdavi SR; Raoufi NJ; Motevalian M; Karimi MY
J Photochem Photobiol B; 2020 Apr; 205():111827. PubMed ID: 32120183
[TBL] [Abstract][Full Text] [Related]
24. Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres.
Gabikian P; Tyler BM; Zhang I; Li KW; Brem H; Walter KA
J Neurosurg; 2014 May; 120(5):1078-85. PubMed ID: 24605841
[TBL] [Abstract][Full Text] [Related]
25. Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulation.
McLaughlin PW; Lawrence TS; Seabury H; Nguyen N; Stetson PL; Greenberg HS; Mancini WR
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):601-7. PubMed ID: 7928491
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
[TBL] [Abstract][Full Text] [Related]
27. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
[TBL] [Abstract][Full Text] [Related]
28. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
[TBL] [Abstract][Full Text] [Related]
29. Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.
Olivi A; Ewend MG; Utsuki T; Tyler B; Domb AJ; Brat DJ; Brem H
Cancer Chemother Pharmacol; 1996; 39(1-2):90-6. PubMed ID: 8995504
[TBL] [Abstract][Full Text] [Related]
30. Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy.
Li Y; Owusu A; Lehnert S
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):519-27. PubMed ID: 14751523
[TBL] [Abstract][Full Text] [Related]
31. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.
Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H
J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595
[TBL] [Abstract][Full Text] [Related]
32. Lactacystin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers.
Legnani FG; Pradilla G; Thai QA; Fiorindi A; Recinos PF; Tyler BM; Gaini SM; DiMeco F; Brem H; Olivi A
J Neurooncol; 2006 May; 77(3):225-32. PubMed ID: 16609837
[TBL] [Abstract][Full Text] [Related]
33. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
[TBL] [Abstract][Full Text] [Related]
34. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
35. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of atomic inner shell ionization (ISI) and Auger cascade for radiosensitization using IUdR, BUdR, platinum salts, or gadolinium porphyrin compounds.
Pignol JP; Rakovitch E; Beachey D; Le Sech C
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1082-91. PubMed ID: 12605988
[TBL] [Abstract][Full Text] [Related]
37. An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116.
Kinsella TJ; Kunugi KA; Vielhuber KA; McCulloch W; Liu SH; Cheng YC
Cancer Res; 1994 May; 54(10):2695-700. PubMed ID: 8168099
[TBL] [Abstract][Full Text] [Related]
38. Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.
Clarke RH; Moosa S; Anzivino M; Wang Y; Floyd DH; Purow BW; Lee KS
PLoS One; 2014; 9(10):e111199. PubMed ID: 25350400
[TBL] [Abstract][Full Text] [Related]
39. Radiosensitization of human glioma cells in vitro and in vivo with acyclovir and mutant HSV-TK75 expressed from adenovirus.
Rosenberg E; Hawkins W; Holmes M; Amir C; Schmidt-Ullrich RK; Lin PS; Valerie K
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):831-6. PubMed ID: 11849808
[TBL] [Abstract][Full Text] [Related]
40. Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma.
Hsu W; Lesniak MS; Tyler B; Brem H
J Neurooncol; 2005 Sep; 74(2):135-40. PubMed ID: 16193383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]